(Q44427680)

2 December 2017

title

Bcr-Abl-mediated resistance to apoptosis is independent of constant tyrosine-kinase activity (English)

1 reference

Gustavo P. Amarante-Mendes

2 December 2017

author

5

object named as

Amarante-Mendes GP

1 reference

2 December 2017

Bueno-da-Silva AE

1

1 reference

2 December 2017

Brumatti G

2

1 reference

2 December 2017

Russo FO

3

1 reference

2 December 2017

Green DR

4

1 reference

2 December 2017

publication date

1 May 2003

1 reference

Cell Death & Differentiation

2 December 2017

published in

1 reference

2 December 2017

volume

10

1 reference

2 December 2017

issue

5

1 reference

2 December 2017

page(s)

592-598

1 reference

Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401210

Chronic myelogenous leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401210

Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401210

Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401210

Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401210

Differential complementation of Bcr-Abl point mutants with c-Myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401210

Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401210

A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401210

Bcl-2-independent Bcr-Abl-mediated resistance to apoptosis: protection is correlated with up regulation of Bcl-xL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401210

STAT5-Dependent CyclinD1 and Bcl-xL expression in Bcr-Abl-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401210

Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401210

Role of phosphatidylinositol 3-kinase and specific protein kinase B isoforms in the suppression of apoptosis mediated by the Abelson protein-tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401210

Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401210

Bcr - Abl-mediated resistance to apoptosis is independent of PI 3-kinase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401210

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401210

Activation of p65 NF-kappaB protein by p210BCR-ABL in a myeloid cell line (P210BCR-ABL activates p65 NF-kappaB).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401210

A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401210

STI571: targeting BCR-ABL as therapy for CML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401210

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401210

Molecular studies in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401210

Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401210

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401210

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401210

Abrogation of retinoblastoma protein function by c-Abl through tyrosine kinase-dependent and -independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401210

A novel tyrosine kinase-independent function of Drosophila abl correlates with proper subcellular localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401210

BCR-ABL activates pathways mediating cytokine independence and protection against apoptosis in murine hematopoietic cells in a dose-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401210

A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401210

Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401210

Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401210

In vivo eradication of human BCR/ABL-positive leukemia cells with an ABL kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401210

inferred from DOI database lookup

7 January 2021

based on heuristic

Down-regulation of interleukin-3/granulocyte-macrophage colony-stimulating factor receptor beta-chain in BCR-ABL(+) human leukemic cells: association with loss of cytokine-mediated Stat-5 activation and protection from apoptosis after BCR-ABL inhibi

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401210

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.CDD.4401210

1 reference

Dimensions Publication ID

2 December 2017

1042403127

0 references

1 reference